ripertamab

DRUG3 trials

Sponsors

Zhongming Qiu, Mao Jianhua

Conditions

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)FRNS/SDNSMyasthenia Gravis (MG)Ripertamab

Phase 1

Ripertamab for the Treatment of Myasthenia Gravis

Not yet recruitingNCT07372807

Zhongming QiuMyasthenia Gravis (MG)

Start: 2026-02-01End: 2027-12-01Target: 20Updated: 2026-01-28

Phase 3

Ripertamab for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy

Not yet recruitingNCT06858722

Zhongming QiuChronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Start: 2025-03-15End: 2027-12-31Target: 175Updated: 2025-03-05

Unknown Phase

Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome

Not yet recruitingNCT07388810

Mao JianhuaFRNS/SDNS, Ripertamab

Start: 2026-02-01End: 2028-02-01Target: 312Updated: 2026-02-05